Research Focus
Research Highlights
Professor Wolvetang leads three MRFF funded missions, the UQ node of the NNAT Phenomics Australia Initiative and the Australian Organoid Facility at UQ. He collaborates with leading clinical researchers of neurological diseases such as Prof David Coman, Prof Patrick Kwan, Prof Terry O’Brien, and Dr Adeline Vanderver (Washington Children Hospital). Professor Wolvetang further leads a number of industry projects that leverage in-house automation systems, multi-electrode array technology, advanced tranbscriptome analysis methods, and stem cell derived organoid models for testing of therapeutics. He engages with multiple patient advocacy groups such as GC4K, the Massimo Foundation, and BrAshAT to foster the development of novel therapeutics for hereditary spastic paraplegias, hypo-myelinating diseases, and childhood ataxias.
News
-
-
Using ‘live’ brain models in hunt for Alzheimer’s treatment
2 November 2021 -
‘Anti-ageing’ effect promising for Alzheimer’s treatment
3 September 2021 -
Queensland scientist researching rare childhood disease at Oxford
29 November 2017 -
Ageing research centre launched at AIBN
17 October 2016 -
Study offers clue to how cells are programmed
13 February 2015